Carmona, Loreto

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet

Global Health and EpidemiologyHealth Systems, Economic Evaluations, Quality of Life

Cited by 8,888

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet

Global Health and EpidemiologyHealth Systems, Economic Evaluations, Quality of Life

Cited by 8,291

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Strangfeld, A., Schäfer, M., Gianfrancesco, M. A., Lawson-Tovey, S., Liew, J. W., Ljung, L., Mateus, E. F., Richez, C., Santos, M. J., Schmajuk, G., et al. (2021) · Annals of the Rheumatic Diseases

COVID-19 Clinical Research StudiesRheumatoid Arthritis Research and Therapies

Cited by 667

2014 update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

van der Heijde, D., Aletaha, D., Carmona, L., Edwards, C. J., Kvien, T. K., Kouloumas, M., Machado, P., Oliver, S., de Wit, M., & Dougados, M. (2015) · Annals of the Rheumatic Diseases

Clinical practice guidelines implementationDelphi Technique in Research

Cited by 290

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Pablos, J. L., Galindo, M., Carmona, L., Lledó, A., Retuerto, M., Blanco, R., Gonzalez-Gay, M. A., Martinez-Lopez, D., Castrejón, I., Alvaro-Gracia, J. M., et al. (2020) · Annals of the Rheumatic Diseases

COVID-19 Clinical Research StudiesRheumatoid Arthritis Research and Therapies

Cited by 238

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Sparks, J. A., Wallace, Z. S., Seet, A. M., Gianfrancesco, M. A., Izadi, Z., Hyrich, K. L., Strangfeld, A., Gossec, L., Carmona, L., Mateus, E. F., et al. (2021) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesCOVID-19 Clinical Research Studies

Cited by 238

Patterns and Consequences of Multimorbidity in the General Population: There is No Chronic Disease Management Without Rheumatic Disease Management

Simões, D., Araújo, F. A., Severo, M., Monjardino, T., Cruz, I., Carmona, L., & Lucas, R. (2017) · Arthritis Care & Research

Chronic Disease Management StrategiesMusculoskeletal pain and rehabilitation

Cited by 62

Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review

Maneiro, J. R., Salgado, E., Gomez-Reino, J. J., & Carmona, L. (2012) · Seminars in Arthritis and Rheumatism

Sarcoidosis and Beryllium Toxicity ResearchTuberculosis Research and Epidemiology

Cited by 59